stage iiib ovarian epithelial cancer

Showing 1 - 7 of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Brenner Tumor, Malignant Ascites, Malignant Pleural Effusion Trial in United States (metformin HCl, , Chemotherapy)

Suspended
  • Brenner Tumor
  • +27 more
  • metformin hydrochloride
  • +2 more
  • Birmingham, Alabama
  • +9 more
May 16, 2022

Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer Trial in

Completed
  • Recurrent Fallopian Tube Cancer
  • +23 more
  • ALVAC(2)-NY-ESO-1 (M)/TRICOM vaccine
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 25, 2020

Ovarian Sarcoma, Ovarian Stromal Cancer, Stage I Uterine Sarcoma Trial in Columbus (behavioral, psychological or informational

Completed
  • Ovarian Sarcoma
  • +61 more
  • behavioral, psychological or informational intervention
  • Columbus, Ohio
    Arthur G. James Cancer Hospital and Solove Research Institute at
May 25, 2018

Cancer Survivor, Stage IA Ovarian Epithelial Cancer, Stage IB Ovarian Epithelial Cancer Trial in Duarte (follow-up care, active

Completed
  • Cancer Survivor
  • +9 more
  • follow-up care
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Sep 27, 2017

Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer, Stage IIIA Ovarian Epithelial Cancer Trial in

Completed
  • Recurrent Ovarian Epithelial Cancer
  • +9 more
  • Rochester, Minnesota
    Mayo Clinic
May 6, 2014

Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer Trial

Withdrawn
  • Recurrent Fallopian Tube Cancer
  • +32 more
  • ALVAC(2)-NY-ESO-1 (M)/TRICOM vaccine
  • +3 more
  • (no location specified)
Dec 17, 2013

Recurrent NSCLC, Recurrent Ovarian Epithelial Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx Trial in Chicago

Completed
  • Recurrent Non-small Cell Lung Cancer
  • +29 more
  • erlotinib hydrochloride
  • +3 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jan 8, 2013